ORB Stock News 26.32 05/15/2014 16:46:33 Orbital Sciences Corp

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Orbital Sciences Corp (ORB) 26.32 $ORB

Alliant Beats Q4 Earnings & Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 15, 11:26AM CDT
Alliant Techsystems Inc.'s (ATK) earnings per share and revenues surpassed the Zacks Consensus Estimate in fourth-quarter of fiscal 2014.

ATK Hits Quarterly Targets But Outlook Off Course
at Investor's Business Daily - Thu May 15, 11:06AM CDT
Alliant Techsystems (ATK) beat fiscal fourth-quarter earning estimates amid its shift from focusing primarily on the military market to the home defense and hunting market. Shares of the top U.S. ammunition maker initially fell as much as 7% early...

ATK Reports Fourth Quarter and FY14 Full-Year Operating Results
PR Newswire - Thu May 15, 6:00AM CDT
ATK (NYSE: ATK) today reported operating results for the fourth quarter and Fiscal Year 2014 (FY14), which ended on March 31, 2014.

SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Orbital Sciences Corp. in Connection to the Proposed Merger of the Company with Alliant Techsystems, Inc.
Business Wire - Mon May 12, 2:10PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Orbital Sciences Corp. ("Orbital" or the "Company" (NYSE: ORB) and other violations of state law by the board of directors of Orbital relating to the proposed merger of the Company with Alliant Techsystems, Inc. ("Alliant".

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri May 09, 7:17PM CDT
This week was about shifting from growth to value and next week won't be much different, Cramer says.

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Orbital Sciences Corp. and Its Board of Directors In Connection With the Sale of the Company to Alliant Techsystems, Inc.
Business Wire - Wed May 07, 11:22AM CDT
Levi & Korsinsky is investigating the Board of Directors of Orbital Sciences Corp. ("Orbital" or "the Company" (Nasdaq: ORB) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Alliant Techsystems, Inc. ("Alliant".

ORBITAL SCIENCES CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue May 06, 12:38PM CDT
Rigrodsky & Long, P.A.:

ORBITAL SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Orbital Sciences Corporation
PR Newswire - Mon May 05, 6:44PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of Orbital Sciences Corporation ("Orbital" or the "Company" (NYSE: ORB) to Alliant Techsystems Inc. ("Alliant" (NYSE: ATK) after Alliant spins-off its valuable Sporting Group. Under the terms of the proposed transaction, shareholders of Orbital will receive only 0.449 shares of the remaining Assets of Alliant (after its spin-off of its Sporting Group) for each share of Orbital common stock that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Orbital Sciences Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Alliant Techsystems
Business Wire - Mon May 05, 11:44AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Orbital Sciences Corp. ("Orbital" (NYSE: ORB) related to the proposed merger with Alliant Techsystems, Inc. for shareholders. Under the terms of the transaction, Orbital shareholders will only receive 0.449 shares of Alliant stock. The transaction is dependent on the spin off of Alliant's Sporting group.

To Defend Ukraine, the World Should Hit Russia Where It Hurts: Space
Maxx Chatsko, The Motley Fool - Motley Fool - Sun May 04, 3:00PM CDT
If the Ukraine crisis drags on, then the International Space Station could get involved. Source: NASA/ Wikimedia Commons .  The crisis unfolding in Ukraine has been anything but fun for Western powers. While sanctions have been expanded by both...

NASA Extends Media Accreditation for Next Orbital Sciences Cargo Resupply Mission to International Space Station
PR Newswire - Fri May 02, 9:34AM CDT
Media accreditation has been extended for the launch of the second NASA contracted cargo resupply flight to the International Space Station from Virginia.

Alliant Techsystems Announces Spin-Off: Should Investors Go With the Guns or the Rockets?
Rich Smith, The Motley Fool - Motley Fool - Thu May 01, 9:45AM CDT
Guns and rockets conglomerate Alliant Techsystems spent much of last year buying companies and putting together the building blocks for a marquee business servicing hunters, target shooters, and sporting goods enthusiasts. Then on Tuesday, it...

Technical Data on Equities Reaching New highs -- Research on Banco Santander, Merck, Schlumberger, and Orbital Sciences
PR Newswire - Thu May 01, 3:17AM CDT
The U.S. stock markets on Tuesday, April 29, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,535.37, up 0.53% and the NASDAQ Composite closed at 4,103.54, up 0.72%. The S&P 500 finished the session 0.48% higher at 1,878.33. During the trading session, eight out of ten sectors finished on a higher note. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include Banco Santander S.A. (NYSE: SAN), Merck & Co. Inc. (NYSE: MRK), Schlumberger Ltd (NYSE: SLB) and Orbital Sciences Corp. (NYSE: ORB). Free technical research on SAN, MRK, SLB and ORB can be downloaded upon signing up at:

Harwood Feffer LLP Announces Investigation of Orbital Sciences Corp.
PR Newswire - Wed Apr 30, 9:00PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Orbital Sciences Corp. ("Orbital Sciences" or the "Company" (NYSE: ORB) concerning the proposed acquisition of the Company by Alliant Techsystems, Inc. ("Alliant".

Introducing Orbital ATK -- the Next Big Thing in Space Flight
Rich Smith, The Motley Fool - Motley Fool - Wed Apr 30, 5:04PM CDT
Industrial conglomerate Alliant Techsystems has historically been known best as a maker of ammunition for firearms, and rockets for rocket ships. Last year, however, the company put a lot of time and effort into building up what was, at the time,...

4 Big Stocks on Traders' Radars
at The Street - Wed Apr 30, 12:53PM CDT
Here's how to trade some of th eost active stocks on the market today.

Downgrade Alert for Orbital Sciences (ORB)
Comtex SmarTrend(R) - Wed Apr 30, 7:00AM CDT
Orbital Sciences (NYSE:ORB) was downgraded from Buy to Hold at Keybanc today. The stock closed yesterday at $30.96 on volume of 4.0 million shares, above average daily volume of 292,000. Orbital Sciences Corporation manufactures small space systems for commercial, civil government, and military customers. The Company's primary products are spacecraft and launch vehicles, ground and air-launched rockets, and missile defense boosters. Orbital offers space-related technical services to government agencies and also builds satellite-based transportation management systems.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Two Xinjiang Histories Arrive With a Clear State Lens

Updated Category News Views 162

Dusty chronology rarely carries this much present-day weight. Two books released in Beijing on September 2, The History of China's Xinjiang Region and The Religious History in China's Xinjiang Region, are presented as the most comprehensive works on the subject yet produced by Chinese scholars. That is a sizable claim, and it deserves to be read with both attention and a...

Continue Reading
BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 80

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 0

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
TD Pledges $2 Billion to Financial Strength by 2036

Updated Category News Views 83

A Longer-Term Bet on Household Resilience A bank’s community budget rarely grabs the market by the collar, but TD’s new target deserves more than a polite nod. The bank says it will direct $2 billion, or US$1.4 billion, toward helping people build financial strength across North America over the next decade. That is a sizable commitment, even for an institution with...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 59

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 19

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
RMT’s 12.4% Discount Still Demands a Much Harder Look

Updated Category News Views 119

A $1.84 gap is staring RMT shareholders right in the face. As of October 31, 2026, Royce Micro-Cap Trust carried a net asset value of $14.82 per share while the market price sat at $12.98. That is roughly a 12.4% discount to NAV, and closed-end fund investors should never wave off a spread like that with a lazy shrug. It may be opportunity. It may also be the market...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 126

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Sleep Number’s Couples Pitch Has Some Fine Print Too

Updated Category News Views 40

A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...

Continue Reading
Cloud Optical Demand Is Running Ahead of Supply in 2026

Updated Category News Views 20

Fiber capacity has become the awkward bottleneck nobody can wish away. Dell’Oro Group says the optical transport equipment market expanded 24% year over year in the third quarter of 2026, with large North American cloud providers doing the heavy lifting. More pointedly, optical vendor revenue tied to those cloud customers jumped 75%. That is not a gentle improvement in...

Continue Reading

Top 5 Most Recently Viewed Articles

Raphael Bostic's Forecast for Interest Rate Cuts in 2024

Updated Category News Views 139

Fed's Bostic Discusses Future Interest Rate Cuts Atlanta Federal Reserve President Raphael Bostic has recently shared his insights regarding future interest rate adjustments. At a recent event in Atlanta, Bostic indicated that he has projected a further interest rate decrease of 25 basis points this year. This update follows his review of the central bank's recent...

Continue Reading
Boardwalktech Software to Showcase Innovations at Upcoming Event

Updated Category News Views 169

Boardwalktech Software Demonstrates Commitment to Innovation Boardwalktech Software Corp. (TSXV: BWLK) (OTCQB: BWLKF), recognized as a leader in the Intelligent Information Platform sector, has announced that their CEO and Chairman, Andrew Duncan, is set to present at the highly anticipated Planet MicroCap Showcase. This event, in partnership with MicroCapClub, serves as...

Continue Reading
Michael Saylor Advocates for U.S. Leadership in Cryptocurrency

Updated Category News Views 123

Michael Saylor's Vision for Digital Assets Michael Saylor, the co-founder of Strategy Inc. and a prominent advocate for Bitcoin, recently held discussions with key figures in the House Financial Services Committee. His conversations focused on strategies to position the United States as a leading authority in the world of Bitcoin and cryptocurrencies. The Digital Assets...

Continue Reading
Gents Doctor Unveils Insights on Testosterone Therapy and Health

Updated Category News Views 297

Gents Doctor Shares New Insights on Testosterone Therapy Gents Doctor, a well-known male health clinic led by Dr. Majid Sabour, MD, has recently unveiled two important blog posts that explore significant topics related to Testosterone Replacement Therapy (TRT). These posts are designed to inform men who are interested in improving their health through hormone...

Continue Reading
Promising Results from Phase III POLARIS-1 Study of Olverembatinib

Updated Category News Views 233

Exciting Developments in the Treatment of Ph+ ALL At the recent American Society of Hematology (ASH) meeting, cutting-edge research on Olverembatinib, a promising drug from Ascentage Pharma, highlighted its impressive efficacy for patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The findings from the Phase III...

Continue Reading